Poly(ethylene glycol)-modified thiolated gelatin nanoparticles for glutathione-responsive intracellular DNA delivery

被引:113
作者
Kommareddy, Sushma [1 ]
Amiji, Mansoor [1 ]
机构
[1] Northeastern Univ, Sch Pharm, Dept Pharmceut Sci, Boston, MA 02115 USA
关键词
thiolated gelatin nanoparticles; poly(ethylene glycol); surface modification; DNA delivery; transfection; GENE-THERAPY; IN-VITRO; PERMEABILITY; TUMORS; DRUG;
D O I
10.1016/j.nano.2006.11.005
中图分类号
TB3 [工程材料学];
学科分类号
0805 ; 080502 ;
摘要
Poly(ethylene glycol) (PEG)-modified thiolated gelatin (PEG-SHGel) anoparticles were developed as a long-circulating passively targeted delivery system that responds to intracellular glutathione concentrations to enhance DNA delivery and transfection. Reporter plasmid expressing enhanced green fluorescent protein (EGFP-N1) was encapsulated in the nanoparticles. DNA-containing gelatin (Gel) and thiolated gelatin (SHGe1) nanoparticles were found to have a size range of 220 to 250 nm, whereas surface modification with PEG resulted in particles with a slightly larger size range of 3 10 to 350 nm. PEG modification was confirmed by electron spectroscopy for chemical analysis (ESCA), where an increase in the ether peak intensities of the C1s spectra corresponds to the surface presence of ethylene oxide residues. In addition, the PEG-SHGel nanoparticles released encapsulate plasmid DNA in response to varying concentrations of glutathione (up to 5.0 mM GSH in phosphate-buffered saline, or PBS). The stability of the encapsulated DNA was confirmed by agarose gel electrophoresis. Finally, from the qualitative and quantitative results of in vitro transfection studies in murine fibroblast cells (NIH3T3), PEG-Gel and PEG-SHGel nanoparticles afforded the highest transfection efficiency of the reporter plasmid. The results of these studies show that PEG-modified thiolated gelatin nanoparticles could serve as a very efficient nanoparticulate vector for systemic DNA delivery to solid tumors where the cells are known to have significantly higher intracellular GSH concentrations. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:32 / 42
页数:11
相关论文
共 22 条
[1]   Monomolecular collapse of plasmid DNA into stable virus-like particles [J].
Blessing, T ;
Remy, JS ;
Behr, JP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (04) :1427-1431
[2]   Development of biomaterials for gene therapy [J].
Han, S ;
Mahato, RI ;
Sung, YK ;
Kim, SW .
MOLECULAR THERAPY, 2000, 2 (04) :302-317
[3]  
JAIN RK, 1990, CANCER RES, V50, pS814
[4]   Drug delivery and transport to solid tumors [J].
Jang, SH ;
Wientjes, MG ;
Lu, D ;
Au, JLS .
PHARMACEUTICAL RESEARCH, 2003, 20 (09) :1337-1350
[5]   Long-circulating poly(ethylene glycol)-modified gelatin nanoparticles for intracellular delivery [J].
Kaul, G ;
Amiji, M .
PHARMACEUTICAL RESEARCH, 2002, 19 (07) :1061-1067
[6]   Tumor-targeted gene delivery using poly(ethylene glycol)-modified gelatin nanoparticles:: In vitro and in vivo studies [J].
Kaul, G ;
Amiji, M .
PHARMACEUTICAL RESEARCH, 2005, 22 (06) :951-961
[7]   Biodistribution and targeting potential of poly(ethylene glycol)-modified gelatin nanoparticles in subcutaneous murine tumor model [J].
Kaul, G ;
Amiji, M .
JOURNAL OF DRUG TARGETING, 2004, 12 (9-10) :585-591
[8]   Cellular interactions and in vitro DNA transfection studies with poly(ethylene glycol)-modified gelatin nanoparticles [J].
Kaul, G ;
Amiji, M .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2005, 94 (01) :184-198
[9]   Long-circulating polymeric nanovectors for tumor-selective gene delivery [J].
Kommareddy, S ;
Tiwari, SB ;
Amiji, MM .
TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2005, 4 (06) :615-625
[10]   Preparation and evaluation of thiol-modified gelatin nanoparticles for intracellular DNA delivery in response to glutathione [J].
Kommareddy, S ;
Amiji, M .
BIOCONJUGATE CHEMISTRY, 2005, 16 (06) :1423-1432